ClassID:

96437

C07H19/213 - CPC Classification

Classification description:

Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides ; Anhydro-derivatives thereof sharing nitrogen; Heterocyclic radicals containing only nitrogen atoms as ring hetero atom; Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids containing cyclic phosphate

Recent Application in this class:
#1
20250188111
2025-06-12

CYCLIC PHOSPHORAMIDATE COMPOUNDS

#2
20240366649
2024-11-07

4-ETHYNYL-3-HYDROXY-TETRAHYDROFURANYL-ADENINE PHOSPHORAMIDATES AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS

#3
20240352056
2024-10-24

Improved methods for production of cyclic guanosine-monophosphate analogues

#4
20240317792
2024-09-26

CYCLIC DINUCLEOTIDE METAL COMPOUND, AND PREPARATION AND APPLICATION THEREOF

#5
20240150390
2024-05-09

NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE

#6
20240109933
2024-04-04

NOVEL NUCLEOSIDE ANALOGS AND USE THEREOF IN THERAPEUTIC TREATMENT

#7
20230382932
2023-11-30

Cyclopentane-Based Modulators of STING (Stimulator of Interferon Genes)

#8
20230242568
2023-08-03

POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES

#9
20230242567
2023-08-03

Chiral phosphoramidite auxiliaries and methods of their use

#10
20230167151
2023-06-01

Substituted nucleosides, nucleotides and analogs thereof

#11
20230062181
2023-03-02

ALKYNE CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO

#12
20220402964
2022-12-22

NEW EQUATORIALLY MODIFIED POLYMER LINKED MULTIMERS OF GUANSINE-3', 5'-CYCLIC MONOPHOSPHATES

#13
20220127301
2022-04-28

ASYMMETRIC AUXILIARY GROUP

#14
20220125821
2022-04-28

Cyclic dinucleotide prodrug molecule, preparation method therefor and application thereof

#15
20210380628
2021-12-09

6-mercaptopurine nucleoside analogues

#16
20210355150
2021-11-18

Pyridinium salts as activators in the synthesis of stereodefined oligonucleotides

#17
20210340169
2021-11-04

Cyclic dinucleotide compound and uses thereof

#18
20210317156
2021-10-14

NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES

#19
20210230196
2021-07-29

Cyclopentane-Based Modulators of STING (Stimulator of Interferon Genes)

#20
20210205347
2021-07-08

Compounds, compositions, and methods for the treatment of disease

#21
20210179654
2021-06-17

Efficient method for the preparation of Cangrelor

#22
20210139523
2021-05-13

Substituted nucleosides, nucleotides and analogs thereof

#23
20210060188
2021-03-04

TCO conjugates and methods for delivery of therapeutic agents

#24
20200385420
2020-12-10

Asymmetric auxiliary group

#25
20200317713
2020-10-08

Liver specific delivery-based entecavir prodrug, nucleoside cyclic phosphate compound, and application thereof

#26
20200179431
2020-06-11

Compositions and methods for activating “stimulator of interferon gene”13 dependent signalling

#27
20200140476
2020-05-07

Chiral phosphoramidite auxiliaries and methods of their use

#28
20200102334
2020-04-02

Cyclopentane-based modulators of STING (stimulator of interferon genes)

#29
20200079815
2020-03-12

Cyclic dinucleotides as anticancer agents

#30
20200079813
2020-03-12

Substituted nucleosides, nucleotides and analogs thereof

#31
20190322695
2019-10-24

2′3′-cyclic dinucleotides

#32
20190315795
2019-10-17

Crystalline 3′,5′-cyclic diguanylic acid

#33
20190292214
2019-09-26

Equatorially modified polymer linked multimers of guanosine-3′, 5′-cyclic monophosphates

#34
20190248828
2019-08-15

Cyclic dinucleotides as anticancer agents

#35
20190233463
2019-08-01

Cyclic phosphate substituted nucleoside compounds and methods of use thereof for the treatment of viral diseases

#36
20190177357
2019-06-13

Asymmetric auxiliary group

#37
20190144484
2019-05-16

Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto

#38
20190111163
2019-04-18

TCO conjugates and methods for delivery of therapeutic agents

#39
20190085013
2019-03-21

NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO

#40
20190085011
2019-03-21

Substituted nucleosides, nucleotides and analogs thereof

#41
20190085010
2019-03-21

HCV POLYMERASE INHIBITORS

#42
20190031703
2019-01-31

Substituted nucleosides, nucleotides and analogs thereof

#43
20180064745
2018-03-08

Compositions and methods for activating “stimulator of interferon gene”—dependent signalling

#44
20180050057
2018-02-22

Crystal-water-free calcium dibutyryladenosine cyclophosphate crystal form and preparation method and application thereof

#45
20180044369
2018-02-15

Substituted nucleosides, nucleotides and analogs thereof

#46
20170296664
2017-10-19

4′-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replication

#47
20170283454
2017-10-05

Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use

#48
20170095580
2017-04-06

TCO conjugates and methods for delivery of therapeutic agents

#49
20170087258
2017-03-30

TCO conjugates and methods for delivery of therapeutic agents

#50
20170037077
2017-02-09

Substituted nucleosides, nucleotides and analogs thereof

#51
20170037075
2017-02-09

Substituted nucleosides, nucleotides and analogs thereof

#52
20170029445
2017-02-02

Asymmetric auxiliary group

#53
20160360754
2016-12-15

Herbicidal composition comprising flazasulfuron and an inhibitor of protoporphyrinogen oxidase

#54
20160340380
2016-11-24

HCV polymerase inhibitors

#55
20160264611
2016-09-15

4′-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus RNA replication

#56
20160176911
2016-06-23

Substituted nucleosides, nucleotides and analogs thereof

#57
20160010150
2016-01-14

Single molecule sequencing with two distinct chemistry steps

#58
20150266918
2015-09-24

Bridged-cyclo-ProTides as prodrugs of therapeutic nucleosides and nucleotides

#59
20150225441
2015-08-13

4′-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replication

#60
20150197540
2015-07-16

Asymmetric auxiliary group

#61
20150105341
2015-04-16

Substituted nucleosides, nucleotides and analogs thereof

#62
20150080457
2015-03-19

5′ phosphate mimics

#63
20140303108
2014-10-09

Cyclic nucleotide analogs

#64
20140248242
2014-09-04

Thiophosphate nucleosides for the treatment of HCV

#65
20140206640
2014-07-24

2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases

#66
20140205653
2014-07-24

Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use

#67
20140179910
2014-06-26

Substituted nucleosides, nucleotides and analogs thereof

#68
20140179627
2014-06-26

Substituted nucleosides, nucleotides and analogs thereof

#69
20140178338
2014-06-26

4′-fluoro nucleosides for the treatment of HCV

#70
20140161770
2014-06-12

2′-cyano substituted nucleoside derivatives and methods of use thereof useful for the treatment of viral diseases

#71
20140154211
2014-06-05

2′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases

#72
20140127680
2014-05-08

Single molecule sequencing with two distinct chemistry steps

#73
20140121108
2014-05-01

Herbicidal composition comprising flazasulfuron and an inhibitor of protoporphyrinogen oxidase

#74
20140112887
2014-04-24

2′,4′-bridged nucleosides for HCV infection

#75
20140099283
2014-04-10

2′-chloro nucleoside analogs for HCV infection

#76
20130315867
2013-11-28

3′,5′-cyclic phosphate prodrugs for HCV infection

#77
20120316327
2012-12-13

Synthesis of purine nucleosides

#78
20120178710
2012-07-12

SYNTHESIS OF CYCLIC DIGUANOSINE MONOPHOSPHATE AND THIOPHOSPHATE ANALOGS THEREOF

#79
20120165286
2012-06-28

Cyclic nucleotide analogs

#80
20120157511
2012-06-21

5′ phosphate mimics

#81
20120041057
2012-02-16

Synthesis and characterization of C8 analogs of c-di-GMP

#82
20120040403
2012-02-16

Diguanylate cyclase method of producing the same and its use in the manufacture of cyclic-di-GMP and analogues thereof

#83
20110212437
2011-09-01

Single molecule sequencing with two distinct chemistry steps

#84
20110009606
2011-01-13

Synthesis of 2′,3′— and 3′,5′—cyclic phosphate mono-and oligonucleotides

#85
20100279973
2010-11-04

Synthesis of purine nucleosides

#86
20090215716
2009-08-27

Nitroguanosine-3′ 5′-cyclic monophosphate compound and protein kinase G activating agent

#87
20080293665
2008-11-27

Purine nucleotide derivatives

#88
20070032448
2007-02-08

Sugar modified nucleosides as viral replication inhibitors

#89
20060100166
2006-05-11

Compounds for modulating the activity of exchange proteins directly activated by cAMP (Epacs)